Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EnBioTec Laboratories is a Japanese biotechnology company specializing in the development and commercialization of advanced immunoassay-based diagnostic tools for environmental and food safety monitoring. The company primarily focuses on Enzyme-Linked Immunosorbent Assay (ELISA) kits designed to detect endocrine disruptors, dioxins, and various pesticides in water, soil, and food samples. Their product portfolio includes specialized kits for substances such as Bisphenol A and Nonylphenol, providing rapid and sensitive detection methods for regulatory compliance and research. In addition to product sales, EnBioTec offers contract testing services to support environmental impact assessments and safety screenings. The company's technology is utilized by research institutions and regulatory bodies to ensure public health and ecological integrity. By providing high-throughput screening solutions, EnBioTec facilitates the monitoring of chemical residues that pose risks to human health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EnBioTec Laboratories.